You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The University of Toronto’s Faculty of Medicine is North America’s largest medical school and a major health consortium, boasting nine affiliated teaching hospitals and a network of research institutes. It is where insulin was pioneered, stem cells were first discovered, and famous physicians from Vincent Lam to Sheela Basrur began their careers. But despite all its major accomplishments, the faculty’s impressive history has never before been comprehensively documented. In Partnership for Excellence, senior medical historian and award-winning author Edward Shorter details the Faculty of Medicine’s history from its inception as a small provincial school to its present day status as an international powerhouse. Deeply researched through front-line interviews and primary sources, it ties the story of the faculty and its teaching hospitals to the general history of medicine over this period. Shorter emphasizes the enormous concentration of intellectual energy in the faculty that has allowed it to become the dominant force in Canadian medicine, home to a legion of medical pioneers and achievements.
First multi-year cumulation covers six years: 1965-70.
Balanced, readable, and authoritative, this volume provides a well-tested introduction to basic pharmacology for students of medicine, dentistry, pharmacy, and allied health fields. The fourth edition includes new chapters on drug-induced carcinogenesis and teratogenesis, adverse drug reactions, perinatal pharmacology, geriatric pharmacology, and behavioral pharmacology. The material on clincal pharamacology and therapeutics, formerly a separate section, has been integrated into various chapters throughout the text, where it amplifies and illustrates the basic pharamcological concepts. With over 70 chapters, 46 contributors, an improved format and many new illustrations, the new edition provides a lucid, step-by-step introduction to medical pharmacology.
The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind. But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients. Behind this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.
None
As sites of action for drugs used to treat schizophrenia and Parkinson’s disease, dopamine receptors are among the most validated drug targets for neuropsychiatric disorders. Dopamine receptors are also drug targets or potential targets for other disorders such as substance abuse, depression, Tourette’s syndrome, and attention deficit hyperactivity disorder. Updated from the successful first edition, "The Dopamine Receptors" serves as a reference work on dopamine receptors while also highlighting the areas of research that are most active today. To achieve this goal, authors have written chapters that set a broad area of research in its historical context, rather than focusing on the research output of their own laboratories.
Good,No Highlights,No Markup,all pages are intact, Slight Shelfwear,may have the corners slightly dented, may have slight color changes/slightly damaged spine.
Schizophrenia is often considered one of the most destructive forms of mental illness. Elahe Hessamfar's personal experience with her daughter's illness has led her to ask some pressing and significant questions about the cause and nature of schizophrenia and the Church's role in its treatment. With a candid and revealing look at the history of mental illness, In the Fellowship of His Suffering describes schizophrenia as a variation of human expression. Hessamfar uses a deeply theological rather than pathological approach to interpret the schizophrenic experience and the effect it has on both the patients and their families. Effectively drawing on the Bible as a source of knowledge for under...